BUDGET-IMPACT ANALYSIS OF ADDING THE NEW 10-VALENT PNEUMOCOCCAL CONJUGATE VACCINATION (PHID-CV) TO ROUTINE INFANT VACCINATION IN CANADA

被引:0
|
作者
Ismaila, A. S. [1 ]
Pereira, J. A. [1 ]
Robson, R. C. [1 ]
Talbird, S. E. [2 ]
Standaert, B. A. [3 ]
Rawson, N. S. [1 ]
机构
[1] GlaxoSmithKline Inc, Mississauga, ON, Canada
[2] RTI Hlth Solut, Res Triangle Pk, NC USA
[3] GlaxoSmithKline Biol, Rixensart, Belgium
关键词
D O I
10.1016/S1098-3015(10)75067-1
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:A418 / A418
页数:1
相关论文
共 50 条
  • [31] Immunogenicity and safety of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine (PHiD-CV) co-administered with routine childhood vaccines in Taiwan
    Lin, Tzou-Yien
    Lu, Chun-Yi
    Chang, Luan-Yin
    Chiu, Cheng-Hsun
    Huang, Yhu-Chering
    Bock, Hans L.
    Tang, Haiwen
    Francois, Nancy
    Moreira, Marta
    Schuerman, Lode
    Huang, Li-Min
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2012, 111 (09) : 495 - 503
  • [32] Impact of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) on childhood pneumonia hospitalizations in Brazil two years after introduction
    Scotta, Marcelo Comerlato
    Veras, Tiago Neves
    Klein, Paula Colling
    Tronco, Virginia
    Polack, Fernando P.
    Mattiello, Rita
    Pitrez, Paulo M. C.
    Jones, Marcus H.
    Stein, Renato T.
    Pinto, Leonardo A.
    VACCINE, 2014, 32 (35) : 4495 - 4499
  • [33] Immunogenicity of Routinely Used Childhood Vaccines When Coadministered With the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV)
    Knuf, Markus
    Szenborn, Leszek
    Moro, Masnuel
    Petit, Christian
    Bermal, Nancy
    Bernard, Laurence
    Dieussaert, Ilse
    Schuerman, Lode
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2009, 28 (04) : S97 - S108
  • [34] Antibody Responses Following Administration of 10-Valent Pneumococcal Non-Typeable Haemophilus influenzas Protein D-Conjugate Vaccine (PHiD-CV) in Filipino Infants
    Bermal, N.
    Alberto, E.
    Hernandez, M.
    Pau, V.
    Fanic, A.
    Gatchalian, S.
    Dieussaert, I.
    Schuerman, L.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2008, 12 : E44 - E44
  • [35] Impact Estimate of the 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D-Conjugate Vaccine (PHiD-CV) on Invasive Pneumococcal Disease (IPD) in Middle East and Asian Countries
    Hausdorff, W. P.
    Beckers, F.
    Dagan, R.
    Begg, N.
    Gatchalian, S.
    Schuerman, L.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2008, 12 : E44 - E45
  • [36] Response to McGirr et al.'s Comment on "Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada"
    Wilson, Michele R.
    Wasserman, Matt
    Jadavji, Taj
    Postma, Maarten
    Breton, Marie-Claude
    Peloquin, Francois
    Earnshaw, Stephanie R.
    McDade, Cheryl
    Sings, Heather L.
    Farkouh, Raymond
    INFECTIOUS DISEASES AND THERAPY, 2018, 7 (04) : 539 - 543
  • [37] A 6-year safety surveillance of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in South Korea
    Lee, Soon Min
    Lee, Jang Hoon
    Song, Eun Song
    Kim, Sung Jin
    Kim, Joon Hyung
    Jakes, Rupert W.
    Devadiga, Raghavendra
    Park, Moon Sung
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (12) : 3019 - 3025
  • [38] Response to McGirr et al.'s Comment on “Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada”
    Michele R. Wilson
    Matt Wasserman
    Taj Jadavji
    Maarten Postma
    Marie-Claude Breton
    Francois Peloquin
    Stephanie R. Earnshaw
    Cheryl McDade
    Heather L. Sings
    Raymond Farkouh
    Infectious Diseases and Therapy, 2018, 7 : 539 - 543
  • [39] Immunogenicity of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Compared to the Licensed 7vCRM Vaccine
    Vesikari, Timo
    Wysocki, Jacek
    Chevallier, Bertrand
    Karvonen, Aino
    Czajka, Hanna
    Arsene, Jean-Pierre
    Lommel, Patricia
    Dieussaert, Ilse
    Schuerman, Lode
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2009, 28 (04) : S66 - S76
  • [40] Safety, reactogenicity and immunogenicity of a booster dose of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Malian children
    Dicko, Alassane
    Santara, Gaoussou
    Mahamar, Almahamoudou
    Sidibe, Youssoufa
    Barry, Amadou
    Dicko, Yahia
    Diallo, Aminata
    Dolo, Amagana
    Doumbo, Ogobara
    Shafi, Fakrudeen
    Francois, Nancy
    Strezova, Ana
    Borys, Dorota
    Schuerman, Lode
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2013, 9 (02) : 382 - 388